Interim results from an early-stage clinical trial of a new gene therapy treatment for Parkinson's suggest it could help people with the condition respond better to medication.
A new diabetes drug may have the potential to protect brain cells in Parkinson's, slowing down or stopping the condition's progress, according to research published today.
Parkinson's UK is looking for healthy men in the Oxfordshire area to take part in the Discovery research study, which is funded by the charity.
An abnormal protein normally found in brain cells affected in Parkinson's can move from the gut to the brain, according to new research.
2016's Picturing Parkinson's winner has been announced. Our annual image competition sees scientists submit images that celebrate the art of research.
A new drug treatment for Parkinson's, opicapone, has launched in the UK. It could prolong the effect of levodopa and reduce the number of tablets required.
We're delighted to announce that the European Medicines Agency (EMA) is officially supporting the use of a particular type of brain scan to help people in the earliest stages of Parkinson's to participate in clinical trials.
New research published in the journal ACS Chemical Neuroscience has identified caffeine-like compounds that may tackle the underlying causes of Parkinson's.